Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Innate Pharma buy Letue35

Start price
€5.18
23.11.17 / 50%
Target price
€5.50
24.11.17
Performance (%)
7.53%
End price
€5.57
24.11.17
Summary
This prediction ended on 24.11.17 with a price of €5.57. The BUY prediction by Letue35 finished with a performance of 7.53%. Letue35 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Innate Pharma -1.790% -1.790% -18.704% -38.960%
iShares Core DAX® 0.000% -2.064% 13.111% 16.685%
iShares Nasdaq 100 0.626% -2.884% 37.744% 43.441%
iShares Nikkei 225® 1.568% -5.892% 19.592% 4.617%
iShares S&P 500 0.334% -2.281% 27.745% 41.046%

Comments by Letue35 for this prediction

In the thread Innate Pharma diskutieren
Prediction Buy
Perf. (%) 7.53%
Target price 5.500
Change
Ends at 24.11.17

GAP fill

Der Wert mit einem GAP nach einer Ankündigung eröffnet am lirilumab es Rebound sollte die füllen

Prediction Buy
Perf. (%) 7.53%
Target price 5.500
Change
Ends at 24.11.17

(Zielkurs erreicht)

Stopped prediction by Letue35 for Innate Pharma

buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.54
09.09.20
-
04.11.21
41.59%
05.11.21